Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FBN1 VWF MEGF9 COL28A1 SPON1 MATN1 LAMB1 TECTA FBN3	1.60e-07	188	89	9	GO:0005201
GeneOntologyMolecularFunction	hypotaurine monooxygenase activity	FMO1 FMO2 FMO4	8.50e-07	5	89	3	GO:0047822
GeneOntologyMolecularFunction	N,N-dimethylaniline monooxygenase activity	FMO1 FMO2 FMO4	1.70e-06	6	89	3	GO:0004499
GeneOntologyMolecularFunction	integrin binding	CCN4 FBN1 VWF ADAM9 LAMB1 SVEP1	1.32e-04	175	89	6	GO:0005178
GeneOntologyMolecularFunction	NADP binding	DPYD FMO1 FMO2 FMO4	1.69e-04	62	89	4	GO:0050661
GeneOntologyMolecularFunction	transition metal ion binding	RNF14 SETDB1 DPYD NUDT7 ATP2C1 ADAMDEC1 P2RX7 LMCD1 ZMYND8 NFX1 NSD1 NFXL1 UBR3 PLSCR2 HERC2	2.29e-04	1189	89	15	GO:0046914
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETDB1 NSD1 SMYD5 EZH1	2.42e-04	68	89	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETDB1 NSD1 SMYD5 EZH1	2.56e-04	69	89	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	SETDB1 NSD1 SMYD5 EZH1	2.85e-04	71	89	4	GO:0042054
GeneOntologyMolecularFunction	histone modifying activity	SETDB1 BRCA2 NSD1 SMYD5 EZH1 KDM4B	5.60e-04	229	89	6	GO:0140993
GeneOntologyMolecularFunction	zinc ion binding	RNF14 SETDB1 ADAMDEC1 P2RX7 LMCD1 ZMYND8 NFX1 NSD1 NFXL1 UBR3 PLSCR2 HERC2	5.81e-04	891	89	12	GO:0008270
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	FMO1 FMO2 FMO4	7.51e-04	40	89	3	GO:0016709
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	DPYD FMO1 FMO2 FMO4	8.28e-04	94	89	4	GO:0050660
GeneOntologyMolecularFunction	histone H4K20 methyltransferase activity	NSD1 SMYD5	8.64e-04	10	89	2	GO:0042799
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETDB1 NSD1 EZH1	9.93e-04	44	89	3	GO:0140938
GeneOntologyMolecularFunction	protein methyltransferase activity	SETDB1 NSD1 SMYD5 EZH1	1.16e-03	103	89	4	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	SETDB1 NSD1 SMYD5 EZH1	1.25e-03	105	89	4	GO:0008170
GeneOntologyMolecularFunction	serine-type endopeptidase inhibitor activity	WFDC3 CRIM1 COL28A1 RECK	1.25e-03	105	89	4	GO:0004867
GeneOntologyMolecularFunction	gamma-catenin binding	PTPRK PTPRT	1.26e-03	12	89	2	GO:0045295
GeneOntologyMolecularFunction	heparin binding	CCN4 FBN1 FSTL1 COL28A1 LGR4	1.69e-03	192	89	5	GO:0008201
GeneOntologyMolecularFunction	calcium ion binding	FBN1 ATP2C1 FSTL1 MATN1 FSTL4 PADI6 PLSCR2 DNAH7 FBN3 SVEP1	1.82e-03	749	89	10	GO:0005509
GeneOntologyMolecularFunction	histone H4 methyltransferase activity	NSD1 SMYD5	2.56e-03	17	89	2	GO:0140939
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRK PTPRT	2.56e-03	17	89	2	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRK PTPRT	2.56e-03	17	89	2	GO:0019198
GeneOntologyBiologicalProcess	blastocyst growth	SETDB1 BRCA2 INTS1 ACVR1C PALB2	3.05e-07	33	90	5	GO:0001832
GeneOntologyBiologicalProcess	inner cell mass cell proliferation	SETDB1 BRCA2 INTS1 PALB2	7.72e-07	17	90	4	GO:0001833
GeneOntologyBiologicalProcess	cell-substrate adhesion	PCSK5 KANK1 VWF DLC1 PTPRK TRIP6 ADAM9 LAMB1 TECTA SVEP1	1.20e-05	410	90	10	GO:0031589
GeneOntologyBiologicalProcess	negative regulation of fatty acid oxidation	FMO1 FMO2 FMO4	6.25e-05	18	90	3	GO:0046322
GeneOntologyBiologicalProcess	embryo implantation	PCSK5 INTS1 LAMB1 ACVR1C RECK	6.64e-05	97	90	5	GO:0007566
GeneOntologyCellularComponent	extracellular matrix	CCN4 FBN1 VWF ADAMDEC1 MEGF9 COL28A1 SPON1 MATN1 LAMB1 PLSCR2 TECTA FBN3 SVEP1 OTOG	7.83e-07	656	90	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	CCN4 FBN1 VWF ADAMDEC1 MEGF9 COL28A1 SPON1 MATN1 LAMB1 PLSCR2 TECTA FBN3 SVEP1 OTOG	8.12e-07	658	90	14	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	FBN1 VWF ADAMDEC1 MEGF9 COL28A1 SPON1 MATN1 LAMB1 PLSCR2	4.62e-04	530	90	9	GO:0062023
GeneOntologyCellularComponent	endoplasmic reticulum lumen	PCSK5 FMO1 FBN1 FSTL1 COL28A1 SPON1 LAMB1	5.79e-04	332	90	7	GO:0005788
HumanPheno	Functional intestinal obstruction	ERBB3 BRCA2 PALB2	2.15e-05	10	30	3	HP:0005249
Domain	VWF_dom	CCN4 VWF FSTL1 CRIM1 MUC19 TECTA OTOG	1.12e-09	42	90	7	IPR001007
Domain	EGF-like_dom	PCSK5 FBN1 MEGF9 MATN1 ADAM9 LAMB1 C6 TECTA FBN3 SVEP1 OTOG PEAR1	2.64e-09	249	90	12	IPR000742
Domain	VWC_out	VWF CRIM1 MUC19 TECTA OTOG	2.56e-08	19	90	5	SM00215
Domain	VWFC_2	CCN4 VWF FSTL1 CRIM1 MUC19 TECTA	2.58e-08	38	90	6	PS50184
Domain	EGF	PCSK5 FBN1 MEGF9 MATN1 ADAM9 LAMB1 TECTA FBN3 SVEP1 PEAR1	1.95e-07	235	90	10	SM00181
Domain	TIL	VWF MUC19 TECTA OTOG	2.42e-07	12	90	4	PF01826
Domain	C8	VWF MUC19 TECTA OTOG	2.42e-07	12	90	4	PF08742
Domain	Unchr_dom_Cys-rich	VWF MUC19 TECTA OTOG	3.49e-07	13	90	4	IPR014853
Domain	C8	VWF MUC19 TECTA OTOG	3.49e-07	13	90	4	SM00832
Domain	TIL_dom	VWF MUC19 TECTA OTOG	4.86e-07	14	90	4	IPR002919
Domain	Growth_fac_rcpt_	PCSK5 CCN4 ERBB3 FBN1 CRIM1 LAMB1 FBN3 SVEP1	8.59e-07	156	90	8	IPR009030
Domain	VWD	VWF MUC19 TECTA OTOG	8.78e-07	16	90	4	SM00216
Domain	VWF_type-D	VWF MUC19 TECTA OTOG	8.78e-07	16	90	4	IPR001846
Domain	VWFD	VWF MUC19 TECTA OTOG	8.78e-07	16	90	4	PS51233
Domain	VWD	VWF MUC19 TECTA OTOG	8.78e-07	16	90	4	PF00094
Domain	VWC	CCN4 VWF CRIM1 MUC19 TECTA	1.03e-06	38	90	5	SM00214
Domain	FMO-like	FMO1 FMO2 FMO4	1.07e-06	5	90	3	PF00743
Domain	Flavin_mOase	FMO1 FMO2 FMO4	1.07e-06	5	90	3	IPR000960
Domain	Flavin_mOase-like	FMO1 FMO2 FMO4	1.07e-06	5	90	3	IPR020946
Domain	DiMe-aniline_mOase	FMO1 FMO2 FMO4	1.07e-06	5	90	3	IPR012143
Domain	CT	CCN4 VWF MUC19 OTOG	3.45e-06	22	90	4	SM00041
Domain	EGF_1	FBN1 MEGF9 MATN1 ADAM9 LAMB1 C6 FBN3 SVEP1 PEAR1	3.86e-06	255	90	9	PS00022
Domain	EGF-like_CS	FBN1 MEGF9 MATN1 ADAM9 LAMB1 C6 FBN3 SVEP1 PEAR1	4.66e-06	261	90	9	IPR013032
Domain	EGF_2	FBN1 MEGF9 MATN1 ADAM9 LAMB1 C6 FBN3 SVEP1 PEAR1	5.28e-06	265	90	9	PS01186
Domain	Cys_knot_C	CCN4 VWF MUC19 OTOG	5.90e-06	25	90	4	IPR006207
Domain	CTCK_2	CCN4 VWF MUC19 OTOG	5.90e-06	25	90	4	PS01225
Domain	TSP_1	CCN4 THSD7A SPON1 C6 THSD7B	1.31e-05	63	90	5	PF00090
Domain	TSP1	CCN4 THSD7A SPON1 C6 THSD7B	1.53e-05	65	90	5	SM00209
Domain	TSP1_rpt	CCN4 THSD7A SPON1 C6 THSD7B	1.53e-05	65	90	5	IPR000884
Domain	TSP1	CCN4 THSD7A SPON1 C6 THSD7B	1.53e-05	65	90	5	PS50092
Domain	Zinc_finger_PHD-type_CS	PHF1 ZMYND8 NFX1 NSD1 NFXL1	1.53e-05	65	90	5	IPR019786
Domain	Methyl_CpG_DNA-bd	SETDB1 MBD6 MBD5	1.74e-05	11	90	3	IPR001739
Domain	MBD	SETDB1 MBD6 MBD5	1.74e-05	11	90	3	PF01429
Domain	DNA-bd_dom	SETDB1 MBD6 MBD5	1.74e-05	11	90	3	IPR016177
Domain	MBD	SETDB1 MBD6 MBD5	1.74e-05	11	90	3	SM00391
Domain	MBD	SETDB1 MBD6 MBD5	1.74e-05	11	90	3	PS50982
Domain	EGF_3	FBN1 MATN1 ADAM9 C6 FBN3 SVEP1 OTOG PEAR1	1.78e-05	235	90	8	PS50026
Domain	VWFC_1	CCN4 VWF FSTL1 CRIM1	2.64e-05	36	90	4	PS01208
Domain	Kazal_2	FSTL1 FSTL4 C6 RECK	2.64e-05	36	90	4	PF07648
Domain	SET	SETDB1 NSD1 SMYD5 EZH1	4.45e-05	41	90	4	PF00856
Domain	ZnF_NFX	NFX1 NFXL1	6.87e-05	3	90	2	SM00438
Domain	zf-NF-X1	NFX1 NFXL1	6.87e-05	3	90	2	PF01422
Domain	Znf_NFX1	NFX1 NFXL1	6.87e-05	3	90	2	IPR000967
Domain	FBN	FBN1 FBN3	6.87e-05	3	90	2	IPR011398
Domain	SET	SETDB1 NSD1 SMYD5 EZH1	7.05e-05	46	90	4	SM00317
Domain	KAZAL	FSTL1 FSTL4 C6 RECK	7.05e-05	46	90	4	SM00280
Domain	CTCK_1	CCN4 VWF MUC19	8.38e-05	18	90	3	PS01185
Domain	KAZAL_1	FSTL1 FSTL4 RECK	8.38e-05	18	90	3	PS00282
Domain	SET_dom	SETDB1 NSD1 SMYD5 EZH1	9.80e-05	50	90	4	IPR001214
Domain	SET	SETDB1 NSD1 SMYD5 EZH1	9.80e-05	50	90	4	PS50280
Domain	KAZAL_2	FSTL1 FSTL4 C6 RECK	9.80e-05	50	90	4	PS51465
Domain	Kazal_dom	FSTL1 FSTL4 C6 RECK	1.06e-04	51	90	4	IPR002350
Domain	-	DPYD FMO1 FMO2 FMO4	1.53e-04	56	90	4	3.50.50.60
Domain	VWA	VWF COL28A1 MATN1 SVEP1	1.53e-04	56	90	4	PF00092
Domain	FAD/NAD-binding_dom	DPYD FMO1 FMO2 FMO4	1.64e-04	57	90	4	IPR023753
Domain	PWWP	ZMYND8 NSD1 MBD5	1.79e-04	23	90	3	PF00855
Domain	PWWP_dom	ZMYND8 NSD1 MBD5	1.79e-04	23	90	3	IPR000313
Domain	PWWP	ZMYND8 NSD1 MBD5	2.04e-04	24	90	3	PS50812
Domain	TUDOR	PHF1 SETDB1 KDM4B	2.91e-04	27	90	3	SM00333
Domain	VWC	CCN4 VWF CRIM1	3.25e-04	28	90	3	PF00093
Domain	GF_recep_IV	PCSK5 ERBB3	3.40e-04	6	90	2	PF14843
Domain	GF_recep_IV	PCSK5 ERBB3	3.40e-04	6	90	2	IPR032778
Domain	Tudor	PHF1 SETDB1 KDM4B	4.00e-04	30	90	3	IPR002999
Domain	-	VWF COL28A1 MATN1 SVEP1	4.48e-04	74	90	4	3.40.50.410
Domain	PHD	PHF1 ZMYND8 NSD1 KDM4B	4.72e-04	75	90	4	PF00628
Domain	TB	FBN1 FBN3	4.75e-04	7	90	2	PF00683
Domain	Znf_PHD-finger	PHF1 ZMYND8 NFX1 NSD1	5.75e-04	79	90	4	IPR019787
Domain	-	FBN1 FBN3	6.31e-04	8	90	2	3.90.290.10
Domain	Laminin_EGF	MEGF9 LAMB1 PEAR1	6.33e-04	35	90	3	PF00053
Domain	EGF_Lam	MEGF9 LAMB1 PEAR1	6.33e-04	35	90	3	SM00180
Domain	VWFA	VWF COL28A1 MATN1 SVEP1	6.62e-04	82	90	4	PS50234
Domain	VWA	VWF COL28A1 MATN1 SVEP1	7.25e-04	84	90	4	SM00327
Domain	EGF_CA	FBN1 MATN1 FBN3 SVEP1	7.92e-04	86	90	4	PF07645
Domain	Laminin_EGF	MEGF9 LAMB1 PEAR1	8.08e-04	38	90	3	IPR002049
Domain	TB	FBN1 FBN3	8.09e-04	9	90	2	PS51364
Domain	TB_dom	FBN1 FBN3	8.09e-04	9	90	2	IPR017878
Domain	PHD	PHF1 ZMYND8 NSD1 KDM4B	9.01e-04	89	90	4	SM00249
Domain	Znf_PHD	PHF1 ZMYND8 NSD1 KDM4B	9.79e-04	91	90	4	IPR001965
Domain	Galactose-bd-like	PCSK5 PTPRK LAMB1 HERC2	1.10e-03	94	90	4	IPR008979
Domain	ZF_PHD_2	PHF1 ZMYND8 NSD1 KDM4B	1.15e-03	95	90	4	PS50016
Domain	ZF_PHD_1	PHF1 ZMYND8 NSD1 KDM4B	1.19e-03	96	90	4	PS01359
Domain	VWF_A	VWF COL28A1 MATN1 SVEP1	1.34e-03	99	90	4	IPR002035
Domain	Post-SET_dom	SETDB1 NSD1	2.64e-03	16	90	2	IPR003616
Domain	-	ATP2C1 ATP1A1	2.64e-03	16	90	2	1.20.1110.10
Domain	PostSET	SETDB1 NSD1	2.64e-03	16	90	2	SM00508
Domain	MAM_1	PTPRK PTPRT	2.64e-03	16	90	2	PS00740
Domain	ATPase_P-typ_TM_dom	ATP2C1 ATP1A1	2.64e-03	16	90	2	IPR023298
Domain	POST_SET	SETDB1 NSD1	2.64e-03	16	90	2	PS50868
Domain	EGF_CA	FBN1 MATN1 FBN3 SVEP1	2.87e-03	122	90	4	SM00179
Domain	ATPase_P-typ_cation-transptr_C	ATP2C1 ATP1A1	2.98e-03	17	90	2	IPR006068
Domain	Cation_ATPase_C	ATP2C1 ATP1A1	2.98e-03	17	90	2	PF00689
Domain	MAM	PTPRK PTPRT	2.98e-03	17	90	2	SM00137
Domain	EGF-like_Ca-bd_dom	FBN1 MATN1 FBN3 SVEP1	3.05e-03	124	90	4	IPR001881
Domain	EGF	MATN1 TECTA FBN3 SVEP1	3.23e-03	126	90	4	PF00008
Domain	MAM	PTPRK PTPRT	3.34e-03	18	90	2	PF00629
Domain	Cation_ATPase_N	ATP2C1 ATP1A1	3.34e-03	18	90	2	PF00690
Domain	MAM_dom	PTPRK PTPRT	3.34e-03	18	90	2	IPR000998
Domain	Cation_ATPase_N	ATP2C1 ATP1A1	3.34e-03	18	90	2	SM00831
Domain	MAM_2	PTPRK PTPRT	3.34e-03	18	90	2	PS50060
Domain	Furin_repeat	PCSK5 ERBB3	3.34e-03	18	90	2	IPR006212
Pathway	WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS	FMO1 FMO2 FMO4	1.22e-06	5	71	3	M39449
Pubmed	Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine.	FMO1 FMO2 FMO4	1.68e-08	3	90	3	19262426
Pubmed	The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balance.	FMO1 FMO2 FMO4	1.68e-08	3	90	3	24792439
Pubmed	Defining brain wiring patterns and mechanisms through gene trapping in mice.	CRIM1 PTPRK LGR4 LAMB1	4.11e-08	14	90	4	11242070
Pubmed	The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.	SETDB1 MBD6 MBD5	6.69e-08	4	90	3	23055267
Pubmed	The molecular biology of the flavin-containing monooxygenases of man.	FMO1 FMO2 FMO4	6.69e-08	4	90	3	7720101
Pubmed	The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.	FMO1 FMO2 FMO4	1.67e-07	5	90	3	8128486
Pubmed	Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine.	FMO1 FMO2 FMO4	1.67e-07	5	90	3	32156684
Pubmed	A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities.	FMO1 FMO2 FMO4	1.67e-07	5	90	3	8311461
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	PCSK5 CCN4 FBN1 VWF FSTL1 ADAM9 LAMB1 SVEP1	2.80e-07	248	90	8	24006456
Pubmed	Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.	FMO1 FMO2 FMO4	3.33e-07	6	90	3	12527699
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	LRP12 FBN1 THSD7A NFXL1 UNK	1.18e-06	71	90	5	33541421
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	CCN4 THSD7A SPON1 C6 THSD7B	1.55e-06	75	90	5	20637190
Pubmed	Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.	BRCA2 PALB2	6.62e-06	2	90	2	17200672
Pubmed	Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.	BRCA2 PALB2	6.62e-06	2	90	2	35762214
Pubmed	Breast-cancer risk in families with mutations in PALB2.	BRCA2 PALB2	6.62e-06	2	90	2	25099575
Pubmed	Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains.	BRCA2 PALB2	6.62e-06	2	90	2	22194698
Pubmed	Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.	BRCA2 PALB2	6.62e-06	2	90	2	20589654
Pubmed	The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.	CCN4 ADAM9	6.62e-06	2	90	2	36778124
Pubmed	Analysis of PALB2/FANCN-associated breast cancer families.	BRCA2 PALB2	6.62e-06	2	90	2	17420451
Pubmed	Structural basis for recruitment of BRCA2 by PALB2.	BRCA2 PALB2	6.62e-06	2	90	2	19609323
Pubmed	Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.	BRCA2 PALB2	6.62e-06	2	90	2	20927582
Pubmed	PALB2 regulates recombinational repair through chromatin association and oligomerization.	BRCA2 PALB2	6.62e-06	2	90	2	19423707
Pubmed	Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).	BRCA2 PALB2	6.62e-06	2	90	2	34687993
Pubmed	MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain.	MBD6 MBD5	6.62e-06	2	90	2	24634419
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	6.62e-06	2	90	2	31400758
Pubmed	The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA.	MBD6 MBD5	6.62e-06	2	90	2	20700456
Pubmed	A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.	BRCA2 PALB2	6.62e-06	2	90	2	21637299
Pubmed	Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.	FBN1 FBN3	6.62e-06	2	90	2	15221638
Pubmed	Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.	BRCA2 PALB2	6.62e-06	2	90	2	30410870
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	6.62e-06	2	90	2	37450367
Pubmed	Association analysis of PALB2 and BRCA2 in bipolar disorder and schizophrenia in a scandinavian case-control sample.	BRCA2 PALB2	6.62e-06	2	90	2	20872766
Pubmed	Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family.	FMO2 FMO4	6.62e-06	2	90	2	1417778
Pubmed	Comparative study of methyl-CpG-binding domain proteins.	MBD6 MBD5	6.62e-06	2	90	2	12529184
Pubmed	Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione.	FMO1 FMO2	6.62e-06	2	90	2	15144220
Pubmed	Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.	FBN1 P2RX7 LEPR	9.16e-06	16	90	3	33904407
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	LRP12 FBN1 FSTL1 CRIM1 PTPRK ADAM9 FSTL4 SLITRK5 LGR4 LAMB1 EMC9 RNF213 ATP1A1	1.30e-05	1201	90	13	35696571
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	PCSK5 FBN1 VWF CRIM1 LAMB1	1.44e-05	118	90	5	21078624
Pubmed	Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.	BRCA2 PALB2	1.98e-05	3	90	2	25833210
Pubmed	A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.	BRCA2 PALB2	1.98e-05	3	90	2	27469594
Pubmed	A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways.	VAV3 PEAR1	1.98e-05	3	90	2	19429868
Pubmed	The risk of breast cancer due to PALB2 gene mutations.	BRCA2 PALB2	1.98e-05	3	90	2	28791855
Pubmed	Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors.	BRCA2 PALB2	1.98e-05	3	90	2	33186520
Pubmed	Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors.	BRCA2 PALB2	1.98e-05	3	90	2	32029870
Pubmed	Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks.	BRCA2 PALB2	1.98e-05	3	90	2	24485656
Pubmed	A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.	BRCA2 PALB2	1.98e-05	3	90	2	32669374
Pubmed	Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.	BRCA2 PALB2	1.98e-05	3	90	2	35363308
Pubmed	Reversion-inducing cysteine-rich protein with Kazal motifs and MT1-MMP promote the formation of robust fibrillin fibers.	FBN1 RECK	1.98e-05	3	90	2	32730638
Pubmed	A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development.	BRCA2 PALB2	1.98e-05	3	90	2	26990772
Pubmed	Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.	BRCA2 PALB2	1.98e-05	3	90	2	16793542
Pubmed	Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.	BRCA2 PALB2	1.98e-05	3	90	2	21989927
Pubmed	Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes.	FMO1 FMO2	1.98e-05	3	90	2	30381441
Pubmed	Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.	BRCA2 PALB2	1.98e-05	3	90	2	18501021
Pubmed	Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.	FBN1 BRCA2	1.98e-05	3	90	2	25749384
Pubmed	BRCA and pancreatic cancer.	BRCA2 PALB2	1.98e-05	3	90	2	23846919
Pubmed	Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.	BRCA2 PALB2	1.98e-05	3	90	2	27490902
Pubmed	Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase kappa by proprotein convertase 5.	PCSK5 PTPRK	1.98e-05	3	90	2	21094132
Pubmed	Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.	BRCA2 PALB2	1.98e-05	3	90	2	34036661
Pubmed	Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.	BRCA2 PALB2	1.98e-05	3	90	2	26219241
Pubmed	BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case.	BRCA2 PALB2	1.98e-05	3	90	2	32058061
Pubmed	Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.	BRCA2 PALB2	1.98e-05	3	90	2	20871615
Pubmed	Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.	BRCA2 PALB2	1.98e-05	3	90	2	29802286
Pubmed	PALB2 links BRCA1 and BRCA2 in the DNA-damage response.	BRCA2 PALB2	1.98e-05	3	90	2	19268590
Pubmed	Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.	BRCA2 PALB2	1.98e-05	3	90	2	24285729
Pubmed	Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.	BRCA2 PALB2	1.98e-05	3	90	2	32300229
Pubmed	PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.	BRCA2 PALB2	1.98e-05	3	90	2	30337689
Pubmed	Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.	BRCA2 PALB2	1.98e-05	3	90	2	23935836
Pubmed	Functional proteomics mapping of a human signaling pathway.	RNF14 SETDB1 KANK1 VWF THSD7A ZMYND8 HERC2 FHL2 SVEP1	2.31e-05	591	90	9	15231748
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SETDB1 ERBB3 FBN1 VWF CRIM1 MEGF9 PTPRK KLHL7 ADAM9 ZMYND8 LAMB1 HERC2 RECK	2.64e-05	1285	90	13	35914814
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	DPYD FMO1 FMO2 FMO4	2.67e-05	66	90	4	19898482
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	PCSK5 SETDB1 ACD TRIP6 ZMYND8 LAMB1 UNK MBD6 FHL2	2.89e-05	608	90	9	16713569
Pubmed	PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.	BRCA2 PALB2	3.96e-05	4	90	2	19584259
Pubmed	DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.	ERBB3 BRCA2	3.96e-05	4	90	2	26496879
Pubmed	Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.	BRCA2 PALB2	3.96e-05	4	90	2	28765325
Pubmed	Roles for APRIN (PDS5B) in homologous recombination and in ovarian cancer prediction.	BRCA2 PALB2	3.96e-05	4	90	2	27924011
Pubmed	BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.	BRCA2 PALB2	3.96e-05	4	90	2	26577449
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN3	3.96e-05	4	90	2	25034023
Pubmed	Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.	BRCA2 PALB2	3.96e-05	4	90	2	23110154
Pubmed	Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.	BRCA2 PALB2	3.96e-05	4	90	2	28319063
Pubmed	The contribution of founder mutations to early-onset breast cancer in French-Canadian women.	BRCA2 PALB2	3.96e-05	4	90	2	19863560
Pubmed	Generation and characterization of mice with mesenchyme-specific deletion of the entire ESET histone methyltransferase protein.	SETDB1 MATN1	3.96e-05	4	90	2	29282851
Pubmed	Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing.	BRCA2 PALB2	3.96e-05	4	90	2	32531196
Pubmed	BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.	BRCA2 PALB2	3.96e-05	4	90	2	25356972
Pubmed	Defects of FA/BRCA pathway in lymphoma cell lines.	BRCA2 PALB2	3.96e-05	4	90	2	19011769
Pubmed	Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.	BRCA2 PALB2	3.96e-05	4	90	2	25113031
Pubmed	Asprosin is a centrally acting orexigenic hormone.	FBN1 LEPR	3.96e-05	4	90	2	29106398
Pubmed	Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.	BRCA2 PALB2	3.96e-05	4	90	2	29470806
Pubmed	Quantitative analysis of FMO gene mRNA levels in human tissues.	FMO1 FMO2	3.96e-05	4	90	2	16183778
Pubmed	A tectorin-based matrix and planar cell polarity genes are required for normal collagen-fibril orientation in the developing tectorial membrane.	TECTA OTOG	3.96e-05	4	90	2	28935705
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATP2C1 THSD7A SPON1 SLITRK5 RNF213 UBR3 ARHGAP35 MBD5	4.32e-05	493	90	8	15368895
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	FBN1 VWF ADAMDEC1 COL28A1 LAMB1	5.02e-05	153	90	5	25037231
Pubmed	Evaluation of candidate genes for cholinesterase activity in farmworkers exposed to organophosphorus pesticides: association of single nucleotide polymorphisms in BCHE.	FMO1 FMO2 FMO4	6.47e-05	30	90	3	20529763
Pubmed	FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males.	FBXW10B FBXW10	6.59e-05	5	90	2	37277019
Pubmed	BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability.	BRCA2 PALB2	6.59e-05	5	90	2	24835992
Pubmed	Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.	BRCA2 PALB2	6.59e-05	5	90	2	25652403
Pubmed	MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.	BRCA2 PALB2	6.59e-05	5	90	2	23038782
Pubmed	Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration.	BRCA2 PALB2	6.59e-05	5	90	2	35404932
Pubmed	Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.	BRCA2 PALB2	6.59e-05	5	90	2	36623243
Pubmed	Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.	BRCA2 PALB2	6.59e-05	5	90	2	31877165
Pubmed	Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.	BRCA2 PALB2	6.59e-05	5	90	2	19748364
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FBN1 VWF COL28A1 SPON1 LAMB1	7.60e-05	167	90	5	22159717
Interaction	FMO4 interactions	FMO1 FMO2 FMO4	2.69e-06	7	87	3	int:FMO4
Interaction	LYPD1 interactions	PCSK5 PTPRK ADAM9 LAMB1 PLSCR2	5.11e-06	58	87	5	int:LYPD1
Cytoband	1q24.3	FMO1 FMO2 FMO4	8.11e-06	20	90	3	1q24.3
Cytoband	3q11.2	OR5K2 OR5K1	1.20e-03	26	90	2	3q11.2
Cytoband	7p21.3	THSD7A COL28A1	1.39e-03	28	90	2	7p21.3
Cytoband	12p13.3	VWF NCAPD2	1.60e-03	30	90	2	12p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q24	FMO1 FMO2 FMO4	2.13e-03	129	90	3	chr1q24
Cytoband	7q22	TRIP6 LAMB1	2.55e-03	38	90	2	7q22
Cytoband	17p12	FBXW10B FBXW10	4.21e-03	49	90	2	17p12
Cytoband	Ensembl 112 genes in cytogenetic band chr3q11	OR5K2 OR5K1	5.09e-03	54	90	2	chr3q11
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	SETDB1 MBD6 MBD5	7.17e-06	11	65	3	1025
GeneFamily	PWWP domain containing	ZMYND8 NSD1 MBD5	6.50e-05	22	65	3	1147
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETDB1 NSD1 EZH1	2.45e-04	34	65	3	487
GeneFamily	PHD finger proteins	PHF1 ZMYND8 NFX1 NSD1	3.08e-04	90	65	4	88
GeneFamily	Tudor domain containing	PHF1 SETDB1 KDM4B	3.16e-04	37	65	3	780
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	6.85e-04	11	65	2	559
GeneFamily	LIM domain containing	TRIP6 LMCD1 FHL2	1.25e-03	59	65	3	1218
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA2 PALB2	2.32e-03	20	65	2	548
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRK PTPRT	2.56e-03	21	65	2	813
GeneFamily	Zinc fingers MYND-type	ZMYND8 SMYD5	2.56e-03	21	65	2	87
GeneFamily	Immunoglobulin like domain containing	PTPRK FSTL4 LEPR PTPRT	5.13e-03	193	65	4	594
Coexpression	NABA_ECM_GLYCOPROTEINS	CCN4 FBN1 VWF CRIM1 SPON1 MATN1 LAMB1 TECTA FBN3 SVEP1 OTOG	7.67e-11	196	90	11	M3008
Coexpression	NABA_CORE_MATRISOME	CCN4 FBN1 VWF CRIM1 COL28A1 SPON1 MATN1 LAMB1 TECTA FBN3 SVEP1 OTOG	1.85e-10	275	90	12	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	CCN4 FBN1 VWF CRIM1 SPON1 MATN1 LAMB1 TECTA SVEP1 OTOG	1.15e-09	191	90	10	MM17059
Coexpression	NABA_MATRISOME	PCSK5 CCN4 FBN1 VWF FSTL1 CRIM1 ADAMDEC1 MEGF9 CLEC2L COL28A1 SPON1 MATN1 ADAM9 MUC19 LAMB1 TECTA FBN3 SVEP1 OTOG	1.60e-09	1026	90	19	M5889
Coexpression	NABA_CORE_MATRISOME	CCN4 FBN1 VWF CRIM1 COL28A1 SPON1 MATN1 LAMB1 TECTA SVEP1 OTOG	2.29e-09	270	90	11	MM17057
Coexpression	NABA_MATRISOME	PCSK5 CCN4 FBN1 VWF FSTL1 CRIM1 ADAMDEC1 MEGF9 CLEC2L COL28A1 SPON1 MATN1 ADAM9 MUC19 LAMB1 TECTA SVEP1 OTOG	8.08e-09	1008	90	18	MM17056
Coexpression	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	CCN4 DPYD FBN1 THSD7A FSTL1 LMCD1 SPON1 LAMB1 RECK	3.48e-06	352	90	9	M17471
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPERIC	CCN4 KANK1 FMO1 FBN1 FSTL1 PTPRK ADAM9 IFI44 LAMB1 RNF213 LEPR SVEP1	1.75e-05	795	90	12	M39050
Coexpression	TIEN_INTESTINE_PROBIOTICS_6HR_DN	ATP2C1 PSME4 CRIM1 KLHL7 SPON1 FHL2	2.70e-05	170	90	6	M19990
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	BRCA2 ADAM9 LAMB1	4.98e-05	21	90	3	M12459
Coexpression	ERBB2_UP.V1_DN	KANK1 DLC1 ADAM9 IFI44 LAMB1 FHL2	6.16e-05	197	90	6	M2635
Coexpression	HAY_BONE_MARROW_STROMAL	FMO2 FBN1 DLC1 FSTL1 CRIM1 ADAMDEC1 LMCD1 COL28A1 THSD7B LEPR SVEP1	6.38e-05	767	90	11	M39209
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN	KANK1 ATP2C1 CRIM1 ADAMDEC1 ZNF175 NCAPD2	6.51e-05	199	90	6	M9943
Coexpression	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	CCN4 FBN1 VWF FSTL1 ADAMDEC1 LAMB1	8.99e-05	211	90	6	M12225
Coexpression	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	CCN4 FBN1 IFI44 LAMB1	9.47e-05	69	90	4	M10165
Coexpression	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	CCN4 FBN1 IFI44 LAMB1	1.24e-04	74	90	4	M13547
Coexpression	GSE45365_NK_CELL_VS_BCELL_DN	PCSK5 FBXW10 FSTL1 KLRG2 ACVR1C	1.46e-04	145	90	5	M10023
Coexpression	BASSO_HAIRY_CELL_LEUKEMIA_UP	DPYD DLC1 SLITRK5 RECK	1.60e-04	79	90	4	M13859
Coexpression	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	THSD7A LEPR RECK	1.64e-04	31	90	3	M816
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES	NFX1 OR5K2 EZH1 OR5K1	1.68e-04	80	90	4	MM17502
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	FMO1 FBN1 DLC1 FSTL1 CRIM1 PTPRK LMCD1 IFI44 LAMB1 LEPR PEAR1	1.99e-06	439	88	11	GSM777059_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	PCSK5 CCN4 DDIAS FBN1 DLC1 BRCA2 NCAPD2 LGR4 LAMB1 RNF213 ATP1A1 ACVR1C RECK SVEP1	3.13e-06	768	88	14	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	FMO1 FMO2 FBN1 DLC1 THSD7A FSTL1 SPON1 LAMB1 LEPR RECK SVEP1	3.54e-06	466	88	11	GSM777050_500
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	FMO1 FBN1 DLC1 FSTL1 CRIM1 PTPRK LMCD1 IFI44 LAMB1 LEPR	1.71e-05	450	88	10	GSM777063_500
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1	CCN4 WFDC3 FMO1 FBN1 FSTL1 CRIM1 LMCD1 IFI44 RECK SVEP1	2.22e-05	464	88	10	JC_fibro_1000_K1
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	DDIAS FBN1 BRCA2 PTPRK KLHL7 NCAPD2 LGR4 RNF213 THSD7B ACVR1C DNAH7 RECK SVEP1	3.66e-05	831	88	13	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1	PHF1 CCN4 TMEM150A FBN1 VWF SERINC4 RECK	4.56e-05	228	88	7	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K1
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	PCSK5 CCN4 FBN1 DLC1 FSTL1 LGR4 LAMB1 RNF213 THSD7B ACVR1C RECK SVEP1	8.48e-05	777	88	12	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	FMO1 FBN1 DLC1 FSTL1 SPON1 ADAM9 LAMB1 RECK SVEP1	9.51e-05	445	88	9	GSM777043_500
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	FMO2 FBN1 DLC1 FSTL1 CRIM1 LAMB1 FHL2 LEPR SVEP1	1.09e-04	453	88	9	GSM777067_500
CoexpressionAtlas	Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5	FMO2 VWF DLC1 FSTL1 CRIM1 PTPRK IFI44 LAMB1 LEPR	1.14e-04	456	88	9	GSM777032_500
CoexpressionAtlas	Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4	FMO2 VWF DLC1 FSTL1 CRIM1 PTPRK IFI44 LAMB1 LEPR	1.20e-04	459	88	9	GSM777037_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	CCN4 DDIAS DPYD LRP12 FMO2 THSD7A FSTL1 KLHL7 LGR4 PLSCR2 FHL2 LEPR	1.39e-04	819	88	12	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	DDIAS FBN1 KLHL7 NCAPD2 NFXL1 LGR4 RNF213 THSD7B ACVR1C DNAH7 RECK SVEP1	1.52e-04	827	88	12	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	PHF1 FBN1 ATP2C1 DLC1 CRIM1 PTPRK LMCD1 ADAM9 IFI44 PLSCR2 ARHGAP35 FHL2	2.48e-04	872	88	12	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_200	FMO2 PLSCR2	2.52e-04	6	88	2	gudmap_kidney_adult_JuxtaGlom_Ren1_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000	DPYD FMO1 FMO2 IFI44 PLSCR2 LEPR	2.94e-04	218	88	6	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	PCSK5 CCN4 FBN1 DLC1 ACVR1C RECK SVEP1	3.05e-04	310	88	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_200	ADAMDEC1 LMCD1 LEPR	4.09e-04	35	88	3	gudmap_developingKidney_e15.5_Podocyte cells_200_k2
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#5	PHF1 PTPRK LMCD1 LGR4 THSD7B	4.28e-04	152	88	5	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K5
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#5_top-relative-expression-ranked_500	ADAMDEC1 LMCD1 SPON1 LEPR	4.51e-04	86	88	4	gudmap_developingKidney_e15.5_Podocyte cells_500_k5
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	FBN1 FSTL1 LEPR SVEP1	4.72e-04	87	88	4	GSM777050_100
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 KANK1 FMO2 FBN1 VWF THSD7A FSTL1 CLEC2L LMCD1	1.40e-10	184	90	9	f506d0ee48f39d6f59f19554217dfdf0987cc405
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 KANK1 FMO2 FBN1 VWF THSD7A FSTL1 CLEC2L LMCD1	1.40e-10	184	90	9	8bcb1c4bc8ffef74338cdade926a94711de93c64
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FMO2 FBN1 THSD7A FSTL1 LAMB1 C6 FHL2 LEPR SVEP1	1.54e-10	186	90	9	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FMO2 FBN1 THSD7A FSTL1 LAMB1 C6 FHL2 LEPR SVEP1	1.54e-10	186	90	9	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF DLC1 FSTL1 CRIM1 IFI44 LAMB1 VAV3 PLSCR2 LEPR	1.86e-10	190	90	9	9d5242759546be0089981ef1877e4ed5f81face5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FMO2 FBN1 DLC1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	2.45e-10	196	90	9	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FMO2 FBN1 DLC1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	2.45e-10	196	90	9	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 FMO2 VWF THSD7A FSTL1 CRIM1 LMCD1 PALB2	3.44e-09	181	90	8	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 KANK1 FMO2 FBN1 VWF THSD7A FSTL1 LMCD1	3.59e-09	182	90	8	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 KANK1 FMO2 FBN1 VWF THSD7A FSTL1 LMCD1	3.59e-09	182	90	8	d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	FMO2 DLC1 FSTL1 SPON1 LAMB1 FHL2 LEPR SVEP1	4.26e-09	186	90	8	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	5.69e-09	193	90	8	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	5.69e-09	193	90	8	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 CCN4 FMO2 FSTL1 CRIM1 LMCD1 FHL2 RECK	6.17e-09	195	90	8	2eed0332e338d6f0dbcb399d9d36c4611d491b0a
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCN4 FMO2 FBN1 FSTL1 CRIM1 NCAPD2 LAMB1 FHL2	6.17e-09	195	90	8	78cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FMO2 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	6.17e-09	195	90	8	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FMO2 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	6.17e-09	195	90	8	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 FBN1 DLC1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	6.42e-09	196	90	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FMO2 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	6.68e-09	197	90	8	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CCN4 FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	6.95e-09	198	90	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	CCN4 FBN1 DLC1 FSTL1 LMCD1 SPON1 FHL2 SVEP1	6.95e-09	198	90	8	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CCN4 FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	6.95e-09	198	90	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FBXW10 FMO1 FBN1 FSTL1 C6 FHL2 SVEP1 PEAR1	7.23e-09	199	90	8	dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CCN4 FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	7.23e-09	199	90	8	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBN1 FSTL1 SPON1 ADAM9 SLITRK5 LAMB1 RECK SVEP1	7.23e-09	199	90	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FBXW10 FMO1 FBN1 FSTL1 C6 FHL2 SVEP1 PEAR1	7.23e-09	199	90	8	c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	CCN4 FBN1 DLC1 FSTL1 LMCD1 SPON1 FHL2 SVEP1	7.23e-09	199	90	8	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO1 FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.52e-09	200	90	8	44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 FBN1 DLC1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.52e-09	200	90	8	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 LEPR SVEP1	7.52e-09	200	90	8	efdf7066b7dd43e35dbc0d2719b75f250cf54af2
ToppCell	cellseq2-Mesenchymal-Fibroblastic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO1 FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.52e-09	200	90	8	1c10597edd532bf172ca09870a937d35e2585081
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CCN4 FBN1 FSTL1 SPON1 ADAM9 SLITRK5 LAMB1 SVEP1	7.52e-09	200	90	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO1 FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.52e-09	200	90	8	440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 FMO2 VWF THSD7A FSTL1 CRIM1 LEPR	4.73e-08	166	90	7	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 FMO2 VWF THSD7A FSTL1 CRIM1 LEPR	4.73e-08	166	90	7	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.07e-08	176	90	7	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	7.07e-08	176	90	7	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KANK1 VWF THSD7A FSTL1 CRIM1 LMCD1 PLSCR2	7.35e-08	177	90	7	6f6cf93893daac6ae228df36219ee3acf8de8f97
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 FMO1 FMO2 VWF THSD7A FSTL1 CRIM1	8.56e-08	181	90	7	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 FMO1 FMO2 VWF THSD7A FSTL1 CRIM1	9.23e-08	183	90	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 KANK1 VWF THSD7A FSTL1 CRIM1 LMCD1	9.23e-08	183	90	7	12e876d6205af8aad74265c668b5e95b9e7487f3
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	FMO2 FBN1 DLC1 FSTL1 SPON1 LEPR SVEP1	9.94e-08	185	90	7	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 KANK1 FBN1 VWF FSTL1 LMCD1 RECK	1.03e-07	186	90	7	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ERBB3 KANK1 DLC1 PTPRK LGR4 THSD7B MBD5	1.07e-07	187	90	7	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FBN1 VWF THSD7A LMCD1 THSD7B RECK	1.07e-07	187	90	7	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PCSK5 FMO1 FMO2 VWF THSD7A LMCD1 ATP1A1	1.11e-07	188	90	7	5bc1537e079c7435196c163bff5f639ea392a33a
ToppCell	-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	CCN4 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.11e-07	188	90	7	038f48e8daaeb72716e975d22a6b004a90654960
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.15e-07	189	90	7	ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.19e-07	190	90	7	7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.19e-07	190	90	7	1004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.19e-07	190	90	7	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.19e-07	190	90	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A FSTL1 PTPRK SPON1 VAV3 ACVR1C PTPRT	1.19e-07	190	90	7	1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.19e-07	190	90	7	7fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.19e-07	190	90	7	10b02c62e72bfea9767e3e751011436925da823e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	1.28e-07	192	90	7	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 THSD7A FSTL1 SPON1 LAMB1 RECK SVEP1	1.28e-07	192	90	7	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	1.28e-07	192	90	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PCSK5 FBN1 VWF FSTL1 SPON1 LAMB1 SVEP1	1.28e-07	192	90	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.28e-07	192	90	7	063e119c4b58957643908f667e6cfd6f7517fd03
ToppCell	droplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FMO1 FMO2 VWF DLC1 FSTL1 CRIM1 LMCD1	1.28e-07	192	90	7	452d54f0aca8657722d7ac61e8422921d08c06b3
ToppCell	droplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FMO1 FMO2 VWF DLC1 FSTL1 CRIM1 LMCD1	1.28e-07	192	90	7	7ddaca206599603d4d0b2afb73ed2850225d277d
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 THSD7A FSTL1 SPON1 LAMB1 RECK SVEP1	1.28e-07	192	90	7	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.28e-07	192	90	7	158cc5736f154da1cb3186ffbf186eae10483e48
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A FSTL1 PTPRK SPON1 VAV3 ACVR1C PTPRT	1.28e-07	192	90	7	25460ca9ebd3d49f666394cf99ab77a5e8f77250
ToppCell	droplet-Lung-30m-Endothelial-venous_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FMO1 FMO2 VWF DLC1 FSTL1 CRIM1 LMCD1	1.28e-07	192	90	7	bf0b996aeedc34a79c71df3379ec9c1aabe06a8c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	1.28e-07	192	90	7	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 CRIM1 LMCD1 LAMB1 LEPR RECK PEAR1	1.28e-07	192	90	7	f4ff62ac9c53eafbe917706de9af8b2d4bded4d4
ToppCell	droplet-Fat-Mat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FMO2 FBN1 FSTL1 LAMB1 RECK SVEP1	1.33e-07	193	90	7	ebd090d7801480b3cee45caac3d30cc991836769
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FMO2 FBN1 FSTL1 LAMB1 RECK SVEP1	1.33e-07	193	90	7	22c58032e58730715224d7934968ce92d150b0e8
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 FBN1 DLC1 LMCD1 SPON1 LAMB1 SVEP1	1.33e-07	193	90	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	CCN4 FMO2 FBN1 LMCD1 SPON1 LAMB1 SVEP1	1.33e-07	193	90	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCN4 FSTL1 CRIM1 LMCD1 COL28A1 SPON1 LAMB1	1.33e-07	193	90	7	7386fadc13a437f3b0c99b5d116cd3c5f893529c
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FMO2 FBN1 FSTL1 LAMB1 RECK SVEP1	1.33e-07	193	90	7	573ad2f848bede1fe20c7b4b352a9242ec294725
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CCN4 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.37e-07	194	90	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	1.37e-07	194	90	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.42e-07	195	90	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FMO2 FBN1 DLC1 LMCD1 SPON1 LAMB1 SVEP1	1.42e-07	195	90	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.42e-07	195	90	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	DPYD FMO2 FBN1 SPON1 LGR4 LAMB1 SVEP1	1.42e-07	195	90	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 KANK1 FMO2 FSTL1 LMCD1 FHL2 RECK	1.42e-07	195	90	7	2414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	FMO2 FBN1 CRIM1 LMCD1 SPON1 LAMB1 SVEP1	1.42e-07	195	90	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.47e-07	196	90	7	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.47e-07	196	90	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CCN4 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.52e-07	197	90	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 LMCD1 SPON1 SVEP1	1.52e-07	197	90	7	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 LMCD1 SPON1 SVEP1	1.52e-07	197	90	7	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 LMCD1 SPON1 SVEP1	1.52e-07	197	90	7	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	FBN1 DLC1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.52e-07	197	90	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCN4 FBN1 DLC1 FSTL1 SPON1 FHL2 SVEP1	1.58e-07	198	90	7	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.58e-07	198	90	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.58e-07	198	90	7	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CCN4 FBN1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	1.63e-07	199	90	7	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CCN4 FBN1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	1.63e-07	199	90	7	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FBN1 DLC1 FSTL1 COL28A1 LAMB1 LEPR SVEP1	1.63e-07	199	90	7	6200618e029063486719479c41eaf31798bd13cf
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 FBN1 FSTL1 SPON1 LAMB1 LEPR SVEP1	1.63e-07	199	90	7	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 FBN1 FSTL1 LMCD1 SPON1 LAMB1 SVEP1	1.63e-07	199	90	7	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	PCSK5 FBN1 DLC1 FSTL1 SPON1 LEPR SVEP1	1.63e-07	199	90	7	f19c683f38bca3bfee40396f27423441051dec67
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CCN4 FBN1 FSTL1 SPON1 LAMB1 FHL2 SVEP1	1.69e-07	200	90	7	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBN1 FSTL1 SPON1 ADAM9 SLITRK5 LAMB1 SVEP1	1.69e-07	200	90	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
Computational	ECM and collagens.	FBN1 VWF THSD7A LMCD1 SPON1 ADAM9 LAMB1 VAV3	2.22e-05	225	57	8	MODULE_47
Computational	Ovary genes.	FBN1 VWF CRIM1 ACD PTPRK TRIP6 SPON1 LAMB1 FHL2	1.23e-04	368	57	9	MODULE_1
Computational	Genes in the cancer module 3.	VWF DLC1 FSTL1 CRIM1 PTPRK TRIP6 ADAM9 LAMB1 FHL2	1.70e-04	384	57	9	MODULE_3
Computational	Neighborhood of CDH11	FBN1 FSTL1 LAMB1	2.99e-04	25	57	3	GNF2_CDH11
Computational	Genes in the cancer module 397.	ACD TRIP6 NCAPD2 LAMB1 HERC2	4.36e-04	121	57	5	MODULE_397
Computational	Neighborhood of PTX3	FBN1 FSTL1 LAMB1	8.92e-04	36	57	3	GNF2_PTX3
Drug	Ccris 2188	FMO1 FMO2 FMO4	5.94e-07	5	90	3	CID000146896
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	ATP2C1 CRIM1 MEGF9 PTPRK ADAM9 LGR4 LAMB1	3.54e-06	161	90	7	3556_DN
Drug	N,N-dimethylaniline-N-oxide	FMO1 FMO2 FMO4	9.63e-06	11	90	3	CID000000950
Disease	Methionine sulfoxide measurement	FMO1 FMO2 FMO4	5.53e-06	12	88	3	EFO_0021650
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	2.63e-05	3	88	2	DOID:65 (implicated_via_orthology)
Disease	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement	SVEP1 PEAR1	5.26e-05	4	88	2	EFO_0803113
Disease	CFTR mutation carrier status	PCSK5 VAV3 THSD7B	5.62e-05	25	88	3	EFO_0021794
Disease	aspartate aminotransferase measurement	SETDB1 ERBB3 THSD7A FSTL4 MUC19 NSD1 RNF213 THSD7B ARHGAP35 CDPF1 LEPR	7.83e-05	904	88	11	EFO_0004736
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA2 PALB2	8.74e-05	5	88	2	DOID:5683 (is_implicated_in)
Disease	social interaction measurement	PHF1 DPYD THSD7B MBD5	1.84e-04	94	88	4	EFO_0009592
Disease	cataract (implicated_via_orthology)	CRIM1 BRCA2 INTS1	2.00e-04	38	88	3	DOID:83 (implicated_via_orthology)
Disease	Alzheimer disease, APOE carrier status	THSD7A OR5K2 OR5K1 KDM4B	2.15e-04	98	88	4	EFO_0007659, MONDO_0004975
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 VWF	2.43e-04	8	88	2	DOID:4783 (biomarker_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	BRCA2 HERC2 PALB2	2.52e-04	41	88	3	C0496956
Disease	Breast adenocarcinoma	BRCA2 HERC2 PALB2	2.52e-04	41	88	3	C0858252
Disease	Pancreatic carcinoma, familial	BRCA2 PALB2	3.12e-04	9	88	2	C2931038
Disease	bipolar disorder	ZNF490 DLC1 THSD7A MATN1 ZMYND8 IFI44 PALB2 SVEP1	3.32e-04	577	88	8	MONDO_0004985
Disease	response to fenofibrate	PCSK5 SPON1 C6	4.54e-04	50	88	3	GO_1901557
Disease	Medulloblastoma	BRCA2 PALB2 KDM4B	4.54e-04	50	88	3	C0025149
Disease	Bipolar Disorder	ERBB3 THSD7A BRCA2 P2RX7 ATP1A1 MBD5 PALB2	5.68e-04	477	88	7	C0005586
Disease	niacinamide measurement	FMO2 FMO4	5.69e-04	12	88	2	EFO_0010511
Disease	Fanconi anemia	BRCA2 PALB2	7.82e-04	14	88	2	cv:C0015625
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA2 PALB2	7.82e-04	14	88	2	C0677776
Disease	autism spectrum disorder (is_implicated_in)	MBD6 MBD5	1.03e-03	16	88	2	DOID:0060041 (is_implicated_in)
Disease	FEV/FEC ratio	PHF1 PCSK5 ERBB3 KANK1 FBN1 DLC1 CRIM1 KLHL7 LMCD1 NSD1 ACVR1C	1.06e-03	1228	88	11	EFO_0004713
Disease	Breast Carcinoma	DPYD ERBB3 BRCA2 HERC2 FHL2 LEPR PALB2	1.15e-03	538	88	7	C0678222
Disease	anorexia nervosa	ERBB3 THSD7A IFI44	1.21e-03	70	88	3	MONDO_0005351
Disease	Bone marrow hypocellularity	BRCA2 PALB2	1.30e-03	18	88	2	C1855710
Disease	Adenocarcinoma of prostate	BRCA2 PALB2	1.61e-03	20	88	2	C0007112
Disease	cortical thickness	ERBB3 FBXW10 FBN1 DLC1 CRIM1 MEGF9 LGR4 ARHGAP35 MBD6 KDM4B	1.76e-03	1113	88	10	EFO_0004840
Disease	small cell lung carcinoma	DLC1 BRCA2 FSTL4	1.78e-03	80	88	3	EFO_0000702
Disease	Leukemia, Myelocytic, Acute	NSD1 FHL2 PALB2 PTPRT	1.81e-03	173	88	4	C0023467
Disease	age at voice drop	THSD7A LEPR	1.95e-03	22	88	2	EFO_0007888
Disease	response to anticonvulsant	THSD7A VAV3 LEPR	2.12e-03	85	88	3	GO_0036277
Disease	sensory peripheral neuropathy, remission	DLC1 PTPRT	2.14e-03	23	88	2	EFO_0009785, MONDO_0002321
Disease	household income	DPYD ERBB3 THSD7A FHL2 PTPRT	2.19e-03	304	88	5	EFO_0009695
Disease	Liver Cirrhosis, Experimental	KANK1 FMO1 FBN1 VWF FSTL1 PLSCR2 FHL2 RECK	2.20e-03	774	88	8	C0023893
Disease	descending aortic diameter	FBN1 LMCD1 CDPF1	2.34e-03	88	88	3	EFO_0021788
Disease	Prostatic Neoplasms	SETDB1 ERBB3 BRCA2 PTPRK ADAM9 VAV3 PALB2	2.47e-03	616	88	7	C0033578
Disease	Malignant neoplasm of prostate	SETDB1 ERBB3 BRCA2 PTPRK ADAM9 VAV3 PALB2	2.47e-03	616	88	7	C0376358
Disease	basal cell carcinoma	KANK1 BRCA2 PADI6 HERC2	2.50e-03	189	88	4	EFO_0004193
Disease	xanthosine measurement	FMO2 FMO4	2.52e-03	25	88	2	EFO_0010549
Disease	Fanconi Anemia	BRCA2 PALB2	2.52e-03	25	88	2	C0015625
Disease	Hypertensive disease	VWF VAV3 ATP1A1 LEPR	2.55e-03	190	88	4	C0020538
Disease	Pancytopenia	BRCA2 PALB2	2.73e-03	26	88	2	C0030312
Disease	Endogenous Hyperinsulinism	FBN1 LEPR	2.73e-03	26	88	2	C1257963
Disease	Exogenous Hyperinsulinism	FBN1 LEPR	2.73e-03	26	88	2	C1257964
Disease	Compensatory Hyperinsulinemia	FBN1 LEPR	2.73e-03	26	88	2	C1257965
Disease	Malignant tumor of breast	BRCA2 PALB2	2.94e-03	27	88	2	cv:C0006142
Disease	Breast neoplasm	BRCA2 PALB2	2.94e-03	27	88	2	cv:C1458155
Disease	caudate volume change measurement, age at assessment	DLC1 UBR3	2.94e-03	27	88	2	EFO_0008007, EFO_0021491
Disease	Familial cancer of breast	BRCA2 PALB2	2.94e-03	27	88	2	cv:C0346153

Protein segments in the cluster

Peptide	Gene	Start	Entry
RDCVAEGKVCDPLCS	ERBB3	491	P21860
CEKGTDSIPLCRKCE	FBXW10	16	Q5XX13
DSIPLCRKCETCVLA	FBXW10	21	Q5XX13
ELSPGLKCVCLLCDS	ACVR1C	21	Q8NER5
CTGCTLCLSVCPIVD	DPYD	986	Q12882
ECRPLGVFECELCTL	CDPF1	6	Q6NVV7
RCPLGVSLITDGCEC	CCN4	61	O95388
TEICKDVDECLSSPC	FBN3	761	Q75N90
PIVETLGCCNVICSD	ATP2C1	336	P98194
AEPPVINEECSLKCC	NSD1	801	Q96L73
LALVDSCCACAITPK	OR5K2	66	Q8NHB8
LTCLADVREPCQLGC	RECK	336	O95980
CEKGTDSIPLCRKCE	FBXW10B	16	O95170
VSCEEVDGCPVILVC	NOL9	291	Q5SY16
VCVLGTEICLDLSGC	PADI6	26	Q6TGC4
TEICLDLSGCAPQKC	PADI6	31	Q6TGC4
SDGTCKCGLECPLNV	MBD6	56	Q96DN6
TCLPESLKCDGNIDC	LRP12	231	Q9Y561
ICVEEDPCACESLVK	MATN1	451	P21941
VPTCGDSCDKVLECG	NFXL1	411	Q6ZNB6
RLPLLLSCCCGDDES	INTS1	1761	Q8N201
VALACDLELDTLPCC	HERC2	3851	O95714
ASESALLKCIELCCG	ATP1A1	451	P05023
LECSGPKADDCELCL	PCSK5	1376	Q92824
PCIVCSCIAGVDFEI	PLSCR2	221	Q9NRY7
ILTESVPCCEDGLTC	MUC19	1316	Q7Z5P9
VPCCEDGLTCSRKII	MUC19	1321	Q7Z5P9
AIACSPIDGECVCKE	PEAR1	456	Q5VY43
PILGPDSCSEVKCCL	DDIAS	961	Q8IXT1
SSIKCCVDEDLEPTC	FMO4	16	P31512
EICCVDKEHKCPLIC	NFX1	701	Q12986
GDCSVDVTVCSPKEC	KANK1	631	Q14678
DDGTSPLIACGKCCL	KDM4B	751	O94953
DATKECLRCPCSAVT	MEGF9	341	Q9H1U4
DPEACDKETGRCLKC	LAMB1	986	P07942
HECCECLVPVPTAKL	LEPR	191	P48357
TVCDCCESFLLTKPV	LGR4	856	Q9BXB1
CLGISVLAECLDCPE	KLHL7	146	Q8IXQ5
VVCCLVPCLIDTDTL	NUDT7	106	P0C024
ICLVSLVFTGCCVPE	SLC2A6	471	Q9UGQ3
TCFVCAKCSEPLVDL	LMCD1	271	Q9NZU5
LALVDSCCACAITPK	OR5K1	66	Q8NHB7
LEACLCGNTAIPVCE	PTPRT	1141	O14522
GCKEPCIITACEDVV	PALB2	881	Q86YC2
ELCCRKKPGACITTS	P2RX7	496	Q99572
KLGLCTPETLFCCDV	IFI44	91	Q8TCB0
PTCCRCKELGLEKED	KLRG2	216	A4D1S0
LITEICGCGPKCKET	COL28A1	781	Q2UY09
SPCDVSLETSDICKC	BRCA2	1946	P51587
PCIPSKLCKIEEADC	C6	126	P13671
ECVEEPEICALGTCS	FBN1	2016	P35555
ASIKCCLEEGLEPTC	FMO1	16	Q01740
CVLSRKTGEPECQCL	FSTL4	76	Q6MZW2
ECAVTEKGEPTCLCI	FSTL1	41	Q12841
LCKGRDIPCSDDCSL	DNAH7	2936	Q8WXX0
GTRALVCLPCDESKC	CRIM1	31	Q9NZV1
CELDPCCEGSTCKLK	ADAM9	436	Q13443
EECGKPIGCDCKDLS	FHL2	41	Q14192
TDGTCKCGLECPLIL	MBD5	56	Q9P267
ISLKCCVDEGLEPTC	FMO2	16	Q99518
RSGECLCLTDCVPLF	EMC9	36	Q9Y3B6
FCPECEKITVAECIE	ZMYND8	126	Q9ULU4
ACLCGETAIPVCEFK	PTPRK	1141	Q15262
SVVPSLEGCCRTCKE	OTOG	2821	Q6ZRI0
AALPGEELLCCVCRS	PHF1	81	O43189
VTDKPILDCCACGTA	SPON1	191	Q9HCB6
EACIIPCPSDCKLSE	THSD7A	1026	Q9UPZ6
TCCTLDDVPLISKCG	TMEM150A	56	Q86TG1
LKCETDIDECSPLPC	SVEP1	1226	Q4LDE5
CKDLVGEFICECPSG	SVEP1	1246	Q4LDE5
KETCPSCPACVDAKI	ARHGAP35	556	Q9NRY4
EKCVSLPDCCHGSEL	DLC1	56	Q96QB1
SVEGKELLCCCGAIE	SETDB1	1271	Q15047
VCLAESCLTLEGPCT	ACD	186	Q96AP0
CCEALTCKLKPGTDC	ADAMDEC1	446	O15204
SILASKGCIKCEAPC	CLEC2L	86	P0C7M8
TEKVACCPLERCSSV	NCAPD2	761	Q15021
CTETCETLTLGPICV	TECTA	996	O75443
PCSICLGDAKDPVCL	RNF213	3996	Q63HN8
TDETCPGVKKCCTLG	WFDC3	91	Q8IUB2
SKSCPCCGTPIEKLD	RNF14	401	Q9UBS8
KCEECGLLLSSEGEC	TRIP6	431	Q15654
VEALCENKEDCPCGK	ZNF490	121	Q9ULM2
LLDEGLCVESTECPC	VWF	336	P04275
ACPCEEKDGILTVSC	SLITRK5	51	O94991
KPSLCFCCPETVEAD	SERINC4	381	A6NH21
LAVRECDPDLCLTCG	EZH1	576	Q92800
CRAAVKCCPEESLKL	PSME4	631	Q14997
CSVCTKVPKDPAVCL	UBR3	1766	Q6ZT12
EKCVIPCPFDCKLSD	THSD7B	991	Q9C0I4
IKPGEEICISYLDCC	SMYD5	341	Q6GMV2
ALCELCAEGSECPIC	UNK	786	Q9C0B0
LTDHTGDIPCICKEC	ZNF175	326	Q9Y473
KCPENDIRSCCLAEI	VAV3	186	Q9UKW4